Does CANRENOIC ACID Cause Epistaxis? 13 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Epistaxis have been filed in association with CANRENOIC ACID. This represents 9.3% of all adverse event reports for CANRENOIC ACID.
13
Reports of Epistaxis with CANRENOIC ACID
9.3%
of all CANRENOIC ACID reports
0
Deaths
13
Hospitalizations
How Dangerous Is Epistaxis From CANRENOIC ACID?
Of the 13 reports, 13 (100.0%) required hospitalization.
Is Epistaxis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANRENOIC ACID. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does CANRENOIC ACID Cause?
Hyperkalaemia (33)
Toxic epidermal necrolysis (33)
Drug hypersensitivity (24)
Off label use (24)
Product use in unapproved indication (20)
Asthenia (16)
Hyponatraemia (14)
Dehydration (11)
Acute kidney injury (10)
Hypotension (10)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
Which CANRENOIC ACID Alternatives Have Lower Epistaxis Risk?
CANRENOIC ACID vs CANRENONE
CANRENOIC ACID vs CANTHARIDIN
CANRENOIC ACID vs CAPECITABINE
CANRENOIC ACID vs CAPIVASERTIB
CANRENOIC ACID vs CAPLACIZUMAB